Previous 10 | Next 10 |
RICHLAND, Wash., May 12, 2020 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE American: ISR) today announced that the Centers for Medicare and Medicaid Services (CMS) has approved 64 ICD-10-PCS billing codes used for reimbursement of Cesium-131 (Cesium Blu™) for the hospital in-patient DR...
RICHLAND, Wash., May 04, 2020 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in brachytherapy powering expanding treatment options throughout the body, today announced that it will host a conference call to discuss its financial res...
Some 10 weeks ago, we saw a lot of potential in shares of IsoRay (ISR), a company which is the sole user of Cesium-131, which outperforms other isotopes in brachytherapy (a treatment for certain cancers). We won't regurgitate those advantages and the markets which we discussed in the previ...
IsoRay, Inc. (ISR) Q2 2020 Results Earnings Conference Call February 11, 2020, 04:30 PM ET Company Participants Mark Levin - IR Lori Woods - CEO Jonathan Hunt - CFO Conference Call Participants Jason Kolbert - Dawson James Ed Woo - Ascendiant Capital Swayampakula Ramaka...
Revenue Increased 16% Year-Over-Year Gross Profit Increased 45% Year-Over-Year RICHLAND, Wash., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the b...
5 Penny Stocks That Have Started To Turn Heads In February Penny stocks are typically regarded as high-risk stocks and for good reason. However, at the same time, it should be noted that there are potentially high rewards to be had as well. That is, if an investor is able to discover promisi...
Editor's note: Seeking Alpha is proud to welcome Accord Partners as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA PREMIUM. Click here to find out more » Summary After y...
RICHLAND, WASH., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE American: ISR) today announced an executed agreement with MIM Software to deliver a novel one-stop-provides-all program to treat head and neck cancer. The new offering bundles MIM’s software technology and Isoray...
RICHLAND, Wash., Jan. 31, 2020 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced that it will host a conference call to discuss its financial res...
Some Penny Stocks To Watch Ahead Of Tuesday’s Open This week is a shortened week thanks to Martin Luther King, Jr. Day on January 20th. In observation of the holiday, U.S. markets will be closed. However, trading will resume once again on the 21st. Given that fact, it not only gives tra...
News, Short Squeeze, Breakout and More Instantly...
IsoRay Inc. Company Name:
ISR Stock Symbol:
NYSE Market:
RICHLAND, Wash. and CORALVILLE, Iowa, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (formerly known as Isoray, Inc.) (NYSE AMERICAN: ISR), a precision oncology company developing alpha-particle therapies and complementary diagnostic imaging agents and an innovator in seed b...
C omp any’s focus is on the advancement of cancer treatments using radiation, radiopharmaceuticals, and imaging technologies New corporate tagline and website introduced N ew ticker symbol to be NYSE American: CATX RICHLAND,...
The combination delivers the promise of bringing powerful new perspectives to the rapidly emerging field of Alpha-Particle radiopharmaceuticals Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, today announced the successful complet...